Advanced GLP-1 Therapy for Medical Weight Management
Semaglutide is a clinically studied GLP-1 receptor agonist that mimics a naturally occurring hormone responsible for regulating appetite, blood sugar, and feelings of fullness. First FDA-approved in 2017 for Type 2 diabetes, semaglutide has since become an important advancement in medical weight management and is the active ingredient in medications such as Ozempic and Wegovy.
Semaglutide works by stimulating glucose-dependent insulin secretion, reducing inappropriate glucagon release, and slowing gastric emptying. It also acts on appetite-regulating pathways in the brain to reduce hunger, minimize food cravings, and promote longer-lasting satiety.
Clinical studies have demonstrated significant weight reduction when semaglutide is combined with appropriate nutrition, physical activity, and ongoing medical supervision.
At Sunkissed Med Spa, semaglutide therapy is incorporated into a personalized treatment plan with clinical monitoring and body composition assessments to track fat loss, evaluate progress, and help prioritize lean muscle preservation.
Our focus is on achieving meaningful weight loss while supporting long-term metabolic health and sustainable results.